Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Work In Process (2016 - 2025)

Avanos Medical's Work In Process history spans 11 years, with the latest figure at $23.2 million for Q3 2024.

  • For Q3 2024, Work In Process fell 2.52% year-over-year to $23.2 million; the TTM value through Sep 2024 reached $23.2 million, down 2.52%, while the annual FY2023 figure was $19.8 million, 16.81% down from the prior year.
  • Work In Process for Q3 2024 was $23.2 million at Avanos Medical, down from $24.2 million in the prior quarter.
  • Across five years, Work In Process topped out at $34.8 million in Q3 2021 and bottomed at $19.8 million in Q4 2023.
  • The 5-year median for Work In Process is $31.2 million (2023), against an average of $29.1 million.
  • The largest annual shift saw Work In Process rose 16.85% in 2021 before it crashed 31.7% in 2023.
  • A 5-year view of Work In Process shows it stood at $32.3 million in 2020, then rose by 2.79% to $33.2 million in 2021, then fell by 28.31% to $23.8 million in 2022, then dropped by 16.81% to $19.8 million in 2023, then grew by 17.17% to $23.2 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Work In Process are $23.2 million (Q3 2024), $24.2 million (Q2 2024), and $25.8 million (Q1 2024).